Authoratory™
 
This website is accredited by Health On the Net Foundation. Click to verify.
Bookmark and Share

4S Fabre

 

Summary for 2003 [at-glance overview of S Fabre work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author S Fabre. According to available data, in 2003 S Fabre published at least 4 articles. This work was completed in collaboration with several authors including Mariette, C and Monget, P. Many other authors have collaborated with S Fabre as well. There is no information about the funding or the grants awarded to support this work.

Analysis of the article abstracts and the titles suggests that S Fabre professional interests are focused around "bone morphogenetic protein", "french genetic programmes" and "surgery induction chemoradiotherapy". These might also be referred to as "oesophageal cancer", "induction chemoradiotherapy" or "complete response". Statistical analysis shows that S Fabre's writing is likely to contains terms "patients", "chemoradiotherapy", "cancer", "genes", "mutation" and "sheep".

Unfortunately, there is not enough information to establish S Fabre affiliation. Luckily, one email address is on file.

ENFRESRUAccurate information, makes sense to meInaccurate information, needs improvementmake correctionleave commentask question

Images [images we found on the Internet for S Fabre]

    loading...

    Do you know S Fabre who matches the profile above? Click the photo and let us know!

Alternative names (2) [other authors with names similar to S Fabre]

Year 2003 Charts [S Fabre frequent coauthors and the most common unique vocabulary terms for the selected year]

  • S Fabre - Coauthors & Social Network in 2003S Fabre - Unique Vocabulary, Keywords and Interests in 2003

Historical Performance Charts [graphical overview of S Fabre publication and funding history for the range of years]

  • S Fabre - Publications and Funding History in 2003

Other [context-specific ads]

Science Trivia (2) [Interactive math & science trivia questions]